Literature DB >> 14531721

Dietary effects on drug metabolism and transport.

Robert Z Harris1, Graham R Jang, Shirley Tsunoda.   

Abstract

Metabolic food-drug interactions occur when the consumption of a particular food modulates the activity of a drug-metabolising enzyme system, resulting in an alteration of the pharmacokinetics of drugs metabolised by that system. A number of these interactions have been reported. Foods that contain complex mixtures of phytochemicals, such as fruits, vegetables, herbs, spices and teas, have the greatest potential to induce or inhibit the activity of drug-metabolising enzymes, although dietary macroconstituents (i.e. total protein, fat and carbohydrate ratios, and total energy intake) can also have effects. Particularly large interactions may result from the consumption of herbal dietary supplements. Cytochrome P450 (CYP) 3A4 appears to be especially sensitive to dietary effects, as demonstrated by reports of potentially clinically important interactions involving orally administered drugs that are substrates of this enzyme. For example, interactions of grapefruit juice with cyclosporin and felodipine, St John's wort with cyclosporin and indinavir, and red wine with cyclosporin, have the potential to require dosage adjustment to maintain drug concentrations within their therapeutic windows. The susceptibility of CYP3A4 to modulation by food constituents may be related to its high level of expression in the intestine, as well as its broad substrate specificity. Reported ethnic differences in the activity of this enzyme may be partly due to dietary factors. Food-drug interactions involving CYP1A2, CYP2E1, glucuronosyltransferases and glutathione S-transferases have also been documented, although most of these interactions are modest in magnitude and clinically relevant only for drugs that have a narrow therapeutic range. Recently, interactions involving drug transporters, including P-glycoprotein and the organic anion transporting polypeptide, have also been identified. Further research is needed to determine the scope, magnitude and clinical importance of food effects on drug metabolism and transport.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14531721     DOI: 10.2165/00003088-200342130-00001

Source DB:  PubMed          Journal:  Clin Pharmacokinet        ISSN: 0312-5963            Impact factor:   6.447


  163 in total

Review 1.  Herbal and alternative medicine.

Authors:  L Nelson; J Perrone
Journal:  Emerg Med Clin North Am       Date:  2000-11       Impact factor: 2.264

2.  Suspected adverse drug events requiring emergency department visits or hospital admissions.

Authors:  R Raschetti; M Morgutti; F Menniti-Ippolito; A Belisari; A Rossignoli; P Longhini; C La Guidara
Journal:  Eur J Clin Pharmacol       Date:  1999-02       Impact factor: 2.953

3.  Effect of grapefruit juice on Sandimmun Neoral absorption among stable renal allograft recipients.

Authors:  C Bistrup; F T Nielsen; U E Jeppesen; H Dieperink
Journal:  Nephrol Dial Transplant       Date:  2001-02       Impact factor: 5.992

4.  Lack of correlation between in vitro and in vivo studies on the effects of tangeretin and tangerine juice on midazolam hydroxylation.

Authors:  J T Backman; J Mäenpää; D J Belle; S A Wrighton; K T Kivistö; P J Neuvonen
Journal:  Clin Pharmacol Ther       Date:  2000-04       Impact factor: 6.875

5.  Effect of grapefruit juice dose on grapefruit juice-triazolam interaction: repeated consumption prolongs triazolam half-life.

Authors:  J J Lilja; K T Kivistö; J T Backman; P J Neuvonen
Journal:  Eur J Clin Pharmacol       Date:  2000-08       Impact factor: 2.953

6.  A novel human hepatic organic anion transporting polypeptide (OATP2). Identification of a liver-specific human organic anion transporting polypeptide and identification of rat and human hydroxymethylglutaryl-CoA reductase inhibitor transporters.

Authors:  B Hsiang; Y Zhu; Z Wang; Y Wu; V Sasseville; W P Yang; T G Kirchgessner
Journal:  J Biol Chem       Date:  1999-12-24       Impact factor: 5.157

Review 7.  Influence of diet and nutritional status on drug metabolism.

Authors:  I Walter-Sack; U Klotz
Journal:  Clin Pharmacokinet       Date:  1996-07       Impact factor: 6.447

8.  CYP3A gene expression in human gut epithelium.

Authors:  J C Kolars; K S Lown; P Schmiedlin-Ren; M Ghosh; C Fang; S A Wrighton; R M Merion; P B Watkins
Journal:  Pharmacogenetics       Date:  1994-10

9.  The fate of naringin in humans: a key to grapefruit juice-drug interactions?

Authors:  U Fuhr; A L Kummert
Journal:  Clin Pharmacol Ther       Date:  1995-10       Impact factor: 6.875

10.  Assessment of cytochrome P4502E1 induction in alcoholic patients by chlorzoxazone pharmacokinetics.

Authors:  C Girre; D Lucas; E Hispard; C Menez; S Dally; J F Menez
Journal:  Biochem Pharmacol       Date:  1994-04-29       Impact factor: 5.858

View more
  38 in total

1.  Possible interactions between dietary fibres and 5-aminosalicylic acid [corrected].

Authors:  Camilla Henriksen; Steen Hansen; Inge Nordgaard-Lassen; Jens Rikardt Anderson; Pia Madsen
Journal:  Therap Adv Gastroenterol       Date:  2010-01       Impact factor: 4.409

Review 2.  Therapeutic drug monitoring and pharmacogenetic tests as tools in pharmacovigilance.

Authors:  Eveline Jaquenoud Sirot; Jan Willem van der Velden; Katharina Rentsch; Chin B Eap; Pierre Baumann
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

Review 3.  Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption.

Authors:  Joseph M Custodio; Chi-Yuan Wu; Leslie Z Benet
Journal:  Adv Drug Deliv Rev       Date:  2007-11-28       Impact factor: 15.470

Review 4.  Potential of pharmacokinetic profiling for detecting herbal interactions with drugs.

Authors:  Veronika Butterweck; Hartmut Derendorf
Journal:  Clin Pharmacokinet       Date:  2008       Impact factor: 6.447

5.  RNA interference screen identifies NAA10 as a regulator of PXR transcription.

Authors:  Peter O Oladimeji; William C Wright; Jing Wu; Taosheng Chen
Journal:  Biochem Pharmacol       Date:  2018-12-16       Impact factor: 5.858

6.  Modulation of CYP3A enzyme activity by diosmin and its consequence on carbamazepine pharmacokinetics in rats.

Authors:  Satish Kumar Bedada; Prasad Neerati
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2017-11-14       Impact factor: 3.000

7.  Silymarin glyceryl monooleate/poloxamer 407 liquid crystalline matrices: physical characterization and enhanced oral bioavailability.

Authors:  Ruyue Lian; Yi Lu; Jianping Qi; Yanan Tan; Mengmeng Niu; Peipei Guan; Fuqiang Hu; Wei Wu
Journal:  AAPS PharmSciTech       Date:  2011-09-23       Impact factor: 3.246

Review 8.  PXR: More Than Just a Master Xenobiotic Receptor.

Authors:  Peter O Oladimeji; Taosheng Chen
Journal:  Mol Pharmacol       Date:  2017-11-07       Impact factor: 4.436

9.  Modulation of Kupffer cells on hepatic drug metabolism.

Authors:  Hong Ding; Jing Tong; Shi-Cheng Wu; Deng-Ke Yin; Xian-Fen Yuan; Jian-Yuan Wu; Jun Chen; Gang-Gang Shi
Journal:  World J Gastroenterol       Date:  2004-05-01       Impact factor: 5.742

Review 10.  [The influence of diet on mental health].

Authors:  C Hausteiner; S Bornschein; T Zilker; H Förstl; J Grassmann
Journal:  Nervenarzt       Date:  2007-06       Impact factor: 1.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.